From ip-health-admin@lists.essential.org  Wed May  2 18:59:09 2007
Return-Path: <ip-health-admin@lists.essential.org>
Received: from lists.essential.org (lists.essential.org [65.222.215.36])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l42Mx9b9028374
	for <ktwarwic@flax9.uwaterloo.ca>; Wed, 2 May 2007 18:59:09 -0400
Received: from lists.essential.org (localhost.localdomain [127.0.0.1])
	by lists.essential.org (Postfix) with ESMTP
	id F27DEB3D8; Wed,  2 May 2007 18:59:05 -0400 (EDT)
Delivered-To: ip-health@lists.essential.org
Received: from questmail.futurequest.net (questmail.futurequest.net [69.5.6.251])
	by lists.essential.org (Postfix) with SMTP id B12ADB3D3
	for <ip-health@lists.essential.org>; Wed,  2 May 2007 18:31:10 -0400 (EDT)
Received: (qmail 15241 invoked by uid 12315); 2 May 2007 22:31:10 -0000
Received: from 68.48.181.109
        (SquirrelMail authenticated user ben.krohmal@keionline.org)
        by QuestMail.FutureQuest.net with HTTP;
        Wed, 2 May 2007 18:31:10 -0400 (EDT)
Message-ID: <3075.68.48.181.109.1178145070.squirrel@QuestMail.FutureQuest.net>
From: ben.krohmal@keionline.org
To: ip-health@lists.essential.org
User-Agent: SquirrelMail/1.4.9a
MIME-Version: 1.0
X-Priority: 3 (Normal)
Importance: Normal
content-transfer-encoding: 7bit
content-type: text/plain;
 charset=iso-8859-1
Subject: [Ip-health] Clinical trials as public goods
Sender: ip-health-admin@lists.essential.org
Errors-To: ip-health-admin@lists.essential.org
X-BeenThere: ip-health@lists.essential.org
Precedence: bulk
List-Help: <mailto:ip-health-request@lists.essential.org?subject=help>
List-Post: <mailto:ip-health@lists.essential.org>
List-Subscribe: <http://lists.essential.org/mailman/listinfo/ip-health>,
	<mailto:ip-health-request@lists.essential.org?subject=subscribe>
List-Id: Discussions of Intellectual Property and Health Care <ip-health.lists.essential.org>
List-Unsubscribe: <http://lists.essential.org/mailman/listinfo/ip-health>,
	<mailto:ip-health-request@lists.essential.org?subject=unsubscribe>
List-Archive: <http://lists.essential.org/pipermail/ip-health/>
X-Original-Date: Wed, 2 May 2007 18:31:10 -0400 (EDT)
Date: Wed, 2 May 2007 18:31:10 -0400 (EDT)

Many of you may be interested in the following article arguing for public
funding of clinical trials:


The Economists' Voice
Vol. 4 (2007) / Issue 1 /
The Case for Public Funding and Public Oversight of Clinical Trials
Available at: http://www.bepress.com/ev/vol4/iss1/art3
     Tracy R. Lewis, Duke University
     Jerome H. Reichman, Duke University
     Anthony D. So, Duke University
Abstract
     Clinical drug trials are public goods and should be publicly
funded to avoid undersupply, the suppression of adverse results and
other problems, according to Tracy R. Lewis, Jerome H. Reichman and
Anthony D. So.
Recommended Citation

_______________________________________________
Ip-health mailing list
Ip-health@lists.essential.org
http://lists.essential.org/mailman/listinfo/ip-health

